February 10, 2023
DNAstack named Company of the Year by Life Sciences Ontario
Award recognizes Toronto company’s global impact on genomics and health research.
May 10, 2022
DNAstack Awarded as Technology Pioneer by World Economic Forum
DNAstack drives medical breakthroughs with its federated data discovery and analysis platform built on open standards. The company was selected for establishing federated data networks and powering insights in pandemic surveillance, neuroscience, rare disease, and oncology.
April 21, 2022
Digital Technology Supercluster Announces Investment to Increase the Effectiveness of Precision Oncology
Harnessing artificial intelligence to take the guesswork out of diagnosing cancer recurrence for millions of cancer survivors
February 9, 2022
DNAstack Launches Viral AI, the First Federated Network for Genomic Variant Surveillance
DNAstack today announced Viral AI, a federated network for genomic variant surveillance and infectious disease research. Viral AI was designed to deliver equitable access to software infrastructure, accelerate international data sharing, and empower scientists and public health officials with globally representative datasets they need to mitigate current and future infectious disease outbreaks.